Research Comparison
Semax vs SNAP-8 (Acetyl Octapeptide-3)
A side-by-side research comparison of Semax and SNAP-8 (Acetyl Octapeptide-3) drawn from Cobalt Peptides' peptide database records.
Semax
Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment, developed in Russia and studied for its effects on the central nervous system. The published literature describes rapid increases in BDNF expression and modulation of dopaminergic and serotonergic signalling. Administered intranasally in study protocols, it is described as reaching the CNS via the olfactory epithelium and trigeminal pathways rather than crossing the blood-brain barrier. Semax is not an approved medicine in the United Kingdom. Supplied strictly as a research compound for laboratory use.
SNAP-8 (Acetyl Octapeptide-3)
SNAP-8 (Acetyl Octapeptide-3) is a synthetic octapeptide developed as a topical alternative to botulinum toxin for reducing dynamic facial wrinkles. It works by mimicking the N-terminal end of SNAP-25 protein to competitively inhibit SNARE complex formation, thereby reducing acetylcholine release at the neuromuscular junction and attenuating the muscle contractions responsible for expression lines. Clinical studies demonstrate significant wrinkle depth reduction with consistent topical application, making it one of the most well-evidenced cosmetic peptides available. Unlike injectable neurotoxins, SNAP-8 is non-invasive, requires no recovery time, and is suitable for use on sensitive areas including the periorbital region.